SLS Stock Analysis: Buy, Sell, or Hold?
SLS - SELLAS Life Sciences Group, Inc. Common Stock
$4.37
-0.59 (-11.82%)
▼
5d:
-8.3%
30d:
-11.28%
90d:
+55.61%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
SLS is down 5.1% this week, but smart money is accumulating calls. Top strike: $6 2026-06-18 with 6,999 OI. Call ratio: 89% View Scanner →
Strength: 6.5/10
Get Alerted When SLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SLS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SLS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SLS is currently trading at $4.37, which is considered oversold relative to its 30-day fair value range of $4.41 to $5.53.
Technical Outlook: Technically, SLS is in a strong uptrend. The price is currently testing key support at $4.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.67 (+98.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLS is in a strong uptrend. The price is currently testing key support at $4.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.67 (+98.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$4.41 -
$5.53
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding SLS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.8%)
- BULLISH: Trading 98.5% below Wall St target ($8.67)
- CAUTION: Recommendation downgraded due to -8.3% 5-day decline
Fair Price Analysis
30-Day Fair Range
$4.41 -
$5.53
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$4.56
Resistance Level
$5.69
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-24.25
Wall Street Target
$8.67
(+98.5%)
Revenue Growth (YoY)
-82.5%
Share & Embed Analysis
Last updated: March 30, 2026 8:55 AM ET
Data refreshes hourly during market hours. Next update: 9:55 AM
Data refreshes hourly during market hours. Next update: 9:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Katherine Bach Kalin
BUY
63400 shares
2025-11-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 60 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 61 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 59 HOLD |
Advanced SLS Option Strategies
Professional options setups generated by AI based on today's SLS price and gamma walls.
